Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Puma Biotechnology
Puma Biotechnology
(PBYI)
Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Nerlynx
Neratinib
2017-07-17
2025-2031
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Neratinib
healthy volunteers/patients
,
liver failure
,
hepatic insufficiency
,
esophageal neoplasms
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
neoplasms
,
triple negative breast neoplasms
,
diarrhea
,
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma
,
stomach neoplasms
,
brain neoplasms
,
colorectal neoplasms
,
inflammatory breast neoplasms
,
lobular carcinoma
,
invasive hydatidiform mole
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
glioblastoma
,
breast neoplasms
,
uterine cervical neoplasms
Fam-trastuzumab deruxtecan-nxki
stomach neoplasms
,
esophageal neoplasms
Ado-trastuzumab emtansine
breast neoplasms
,
brain neoplasms
Albumin
breast neoplasms
Antithrombin iii
breast neoplasms
,
lobular carcinoma
,
invasive hydatidiform mole
Aglatimagene besadenovec
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
adenocarcinoma
Alisertib
lung neoplasms
,
small cell lung carcinoma
,
recurrence
,
breast neoplasms
Edrecolomab
breast neoplasms
Aspartame
breast neoplasms
,
inflammatory breast neoplasms
Bevifimod
healthy volunteers/patients
,
esophageal neoplasms
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
,
adenocarcinoma
,
triple negative breast neoplasms
,
stomach neoplasms
,
brain neoplasms
,
colorectal neoplasms
,
diarrhea
,
inflammatory breast neoplasms
,
lobular carcinoma
,
invasive hydatidiform mole
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
glioblastoma
,
breast neoplasms
Nepidermin
lung neoplasms
,
breast neoplasms
,
brain neoplasms
,
recurrence
Retinol
stomach neoplasms
Hyoscyamine
breast neoplasms
,
adenocarcinoma
,
diarrhea
Caelyx
breast neoplasms
Endocrine
breast neoplasms
,
lobular carcinoma
,
invasive hydatidiform mole
,
recurrence
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use